Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib

Last week, Eli Lilly promised to supply India with thousands of tablets of its arthritis drug baricitinib to aid a surge of hospitalized COVID-19 patients in the country and pledged to work with local companies to bring its supply up to speed. Now, it appears Lilly’s keeping its word.